Related Experiment Video
Updated: Jan 10, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Landiolol for managing atrial fibrillation in intensive care
Sebastian Rehberg1, Michael Joannidis2, Tony Whitehouse3
1Department of Anaesthesiology, University Hospital of Greifswald, Greifswald, Germany.
Abstract:
Landiolol is an injectable ultrashort acting beta-blocker with high beta1 selectivity indicated for heart rate control of atrial fibrillation in the emergency and critical care setting. Accordingly, landiolol is associated with a significantly reduced risk of arterial hypotension and negative inotropic effects. Based on this particular profile along with the clinical experience in Japan for more than a decade landiolol represents a promising agent for the management of elevated heart rate and atrial fibrillation in intensive care patients even with catecholamine requirements. This article provides a review and perspective of landiolol for heart rate control in intensive care patients based on the current literature.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Dysrhythmias VII: Nursing Management of Dysrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Cardiac Catheterization IV: Nursing Management